Somatic hypermutation: activation-induced deaminase for C/G followed by polymerase eta for A/T
- PMID: 17190841
- PMCID: PMC2118430
- DOI: 10.1084/jem.20062409
Somatic hypermutation: activation-induced deaminase for C/G followed by polymerase eta for A/T
Abstract
Somatic hypermutation (SHM) introduces nucleotide substitutions into immunoglobulin variable (Ig V) region genes at all four bases, but the mutations at C/G and A/T pairs are achieved by distinct mechanisms. Mutations at C/G pairs are a direct consequence of the C-->U deamination catalyzed by activation-induced deaminase (AID). Mutations at A/T pairs, however, require a second mutagenic process that occurs during patch repair of the AID-generated U/G mismatch. Several DNA polymerases have been proposed to play a role in SHM, but accumulating evidence indicates that the mutations at A/T are overwhelmingly achieved by recruitment of DNA polymerase eta.
Figures

Comment on
-
DNA polymerase eta is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse.J Exp Med. 2007 Jan 22;204(1):17-23. doi: 10.1084/jem.20062131. Epub 2006 Dec 26. J Exp Med. 2007. PMID: 17190840 Free PMC article.
Similar articles
-
Antibody diversification caused by disrupted mismatch repair and promiscuous DNA polymerases.DNA Repair (Amst). 2016 Feb;38:110-116. doi: 10.1016/j.dnarep.2015.11.011. Epub 2015 Dec 2. DNA Repair (Amst). 2016. PMID: 26719140 Free PMC article. Review.
-
Molecular mechanisms of antibody somatic hypermutation.Annu Rev Biochem. 2007;76:1-22. doi: 10.1146/annurev.biochem.76.061705.090740. Annu Rev Biochem. 2007. PMID: 17328676 Review.
-
An update on the role of translesion synthesis DNA polymerases in Ig hypermutation.Trends Immunol. 2005 Apr;26(4):215-20. doi: 10.1016/j.it.2005.02.008. Trends Immunol. 2005. PMID: 15797512 Review.
-
Reflections on the state of play in somatic hypermutation.Mol Immunol. 2008 May;45(10):2723-6. doi: 10.1016/j.molimm.2008.02.002. Epub 2008 Mar 21. Mol Immunol. 2008. PMID: 18359085
-
Characterization of Ig gene somatic hypermutation in the absence of activation-induced cytidine deaminase.J Immunol. 2008 Jul 15;181(2):1299-306. doi: 10.4049/jimmunol.181.2.1299. J Immunol. 2008. PMID: 18606684 Free PMC article.
Cited by
-
High-fidelity correction of genomic uracil by human mismatch repair activities.BMC Mol Biol. 2008 Oct 27;9:94. doi: 10.1186/1471-2199-9-94. BMC Mol Biol. 2008. PMID: 18954457 Free PMC article.
-
Generation and repair of AID-initiated DNA lesions in B lymphocytes.Front Med. 2014 Jun;8(2):201-16. doi: 10.1007/s11684-014-0324-4. Epub 2014 Apr 21. Front Med. 2014. PMID: 24748462 Free PMC article. Review.
-
The Role of DNA Repair in Immunological Diversity: From Molecular Mechanisms to Clinical Ramifications.Front Immunol. 2022 Apr 1;13:834889. doi: 10.3389/fimmu.2022.834889. eCollection 2022. Front Immunol. 2022. PMID: 35432317 Free PMC article. Review.
-
Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.Immunology. 2009 Mar;126(3):316-28. doi: 10.1111/j.1365-2567.2008.03050.x. Immunology. 2009. PMID: 19302140 Free PMC article. Review.
-
I. VH gene transcription creates stabilized secondary structures for coordinated mutagenesis during somatic hypermutation.Mol Immunol. 2008 Aug;45(13):3589-99. doi: 10.1016/j.molimm.2008.02.030. Epub 2008 Jun 27. Mol Immunol. 2008. PMID: 18585784 Free PMC article.
References
-
- Muramatsu M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102:553–563. - PubMed
-
- Revy, P., T. Muto, Y. Levy, F. Geissmann, A. Plebani, O. Sanal, N. Catalan, M. Forveille, R. Dufourcq-Labelouse, A. Gennery, et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 102:565–575. - PubMed
-
- Rada, C., M.R. Ehrenstein, M.S. Neuberger, and C. Milstein. 1998. Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity. 9:135–141. - PubMed
-
- Zeng, X., D.B. Winter, C. Kasmer, K.H. Kraemer, A.R. Lehmann, and P.J. Gearhart. 2001. DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat. Immunol. 2:537–541. - PubMed